Key statistics
As of last trade IGC Pharma Inc (IGS1:BER) traded at 0.34, 0.00% below its 52-week high of 0.34, set on Mar 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.34 |
Low | 0.34 |
Bid | -- |
Offer | -- |
Previous close | 0.34 |
Average volume | -- |
---|---|
Shares outstanding | 75.64m |
Free float | 69.65m |
P/E (TTM) | -- |
Market cap | 28.89m USD |
EPS (TTM) | -0.2104 USD |
Data delayed at least 15 minutes, as of Mar 20 2024 07:02 BST.
More ▼
Press releases
- IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
- IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease
- IGC Announces Results of its 2024 Annual Stockholders Meeting
- IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
- IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist
More ▼